In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Corteva's current price exceeds its PERT-weighted fair value by 5.5%, indicating potential overvaluation with high leverage and low profitability risks. Monte Carlo results show high volatility and significant downside risk (68.6% scenarios below current price), contrasting with a wide value range up to $507.13. Valuation methods vary widely, reflecting uncertainty in growth and cash flow stability.